Peter Wilhelm Schiller
#160,064
Most Influential Person Now
Peter Wilhelm Schiller's AcademicInfluence.com Rankings
Peter Wilhelm Schillerbiology Degrees
Biology
#12598
World Rank
#16084
Historical Rank
Biochemistry
#2164
World Rank
#2309
Historical Rank
Download Badge
Chemistry Biology
Peter Wilhelm Schiller's Degrees
- Masters Chemistry Stanford University
- Bachelors Chemistry Stanford University
Why Is Peter Wilhelm Schiller Influential?
(Suggest an Edit or Addition)Peter Wilhelm Schiller's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury* (2004) (690)
- Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. (1985) (199)
- Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. (1992) (194)
- A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action (2018) (192)
- MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. (2011) (174)
- Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. (1984) (168)
- Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity. (1982) (166)
- Structural basis for bifunctional peptide recognition at human δ-Opioid receptor (2015) (155)
- Bi- or multifunctional opioid peptide drugs. (2010) (153)
- Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity. (1989) (152)
- The Opioid μ Agonist/δ Antagonist DIPP-NH2[Ψ] Produces a Potent Analgesic Effect, No Physical Dependence, and Less Tolerance than Morphine in Rats (1999) (150)
- Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development (2011) (146)
- An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. (1994) (142)
- Transcellular Transport of a Highly Polar 3+ Net Charge Opioid Tetrapeptide (2003) (138)
- Synthesis and in vitro opioid activity profiles of DALDA analogues. (2000) (137)
- Bioluminescence Resonance Energy Transfer Assays Reveal Ligand-specific Conformational Changes within Preformed Signaling Complexes Containing δ-Opioid Receptors and Heterotrimeric G Proteins* (2008) (121)
- Attenuation of morphine tolerance and dependence with the highly selective δ-opioid receptor antagonist TIPP[ψ] (1995) (120)
- TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. (1993) (118)
- Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. (1978) (113)
- Molecular Pharmacology of δ-Opioid Receptors (2016) (111)
- A cyclic enkephalin analog with high in vitro opiate activity. (1980) (103)
- Cyclic enkephalin analogs containing a cystine bridge. (1981) (87)
- Opiate receptor subclasses differ in their conformational requirements (1982) (85)
- The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists. (1999) (85)
- Fluorescent dyes alter intracellular targeting and function of cell‐penetrating tetrapeptides (2005) (85)
- Internalization and Src Activity Regulate the Time Course of ERK Activation by Delta Opioid Receptor Ligands* (2005) (81)
- Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands. (2002) (80)
- A topochemical approach to explain morphiceptin bioactivity. (1993) (80)
- Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-α (TNF-α) Expression in Cardiomyocytes during Lipopolysaccharide Stimulation* (2010) (78)
- Receptor binding, biological, and immunological properties of chemically deglycosylated pituitary lutropin. (1979) (75)
- In vivo pharmacokinetics of selective mu-opioid peptide agonists. (2001) (75)
- Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. (1991) (74)
- Evidence for topographical analogy between methionine-enkephalin and morphine derivatives. (1977) (74)
- Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation. (2001) (72)
- Isolation, structure, and synthesis of a human seminal plasma peptide with inhibin-like activity. (1984) (70)
- [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists. (2001) (67)
- Isolated adrenal cells: ACTH11–24, a competitive antagonist of ACTH1–39 and ACTH1–10 (1971) (64)
- Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries. (1993) (61)
- Profound Spinal Tolerance after Repeated Exposure to a Highly Selective μ-Opioid Peptide Agonist: Role of δ-Opioid Receptors (2002) (55)
- Central Actions and Brain Receptor Binding of Angiotensin II: Influence of Sodium Intake (1980) (55)
- Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes (2014) (54)
- Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. (1984) (52)
- The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. (1999) (52)
- Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA. (2001) (51)
- Comparison of [Dmt1]DALDA and DAMGO in Binding and G Protein Activation at μ, δ, and κ Opioid Receptors (2003) (51)
- Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity. (2007) (49)
- Biological and conformational studies of [Val4]morphiceptin and [D-Val4]morphiceptin analogs incorporating cis-2-aminocyclopentane carboxylic acid as a peptidomimetic for proline. (2009) (48)
- Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects. (1994) (47)
- Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors (2013) (47)
- Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline. (2009) (46)
- Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists (2014) (45)
- Development of receptor-specific opioid peptide analogues. (1991) (45)
- Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position. (1987) (43)
- Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence. (2009) (42)
- Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. (1985) (42)
- Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). (2007) (42)
- Brain receptor binding and central actions of angiotensin analogs in rats. (1981) (41)
- Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide. (2001) (41)
- Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile. (1998) (41)
- Isolation and identification of peptide conformers by reversed-phase high-performance liquid chromatography and NMR at low temperature. (1996) (40)
- Opioid peptide-derived analgesics (2005) (40)
- Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist. (2011) (39)
- Evidence of a peptide backbone contribution toward selective receptor recognition for leucine enkephalin thioamide analogs. (1984) (39)
- Novel ligands lacking a positive charge for the δ- and μ-opioid receptors (2000) (39)
- Conformationally restricted deltorphin analogues. (1992) (39)
- Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence. (2009) (39)
- A novel cyclic opioid peptide analog showing high preference for mu-receptors. (1985) (39)
- Substrate Specificity of Tonin from Rat Submaxillary Gland (1976) (35)
- [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine. (2002) (34)
- Highly potent side‐chain to side‐chain cyclized enkephalin analogues containing a carbonyl bridge: synthesis, biology and conformation (2001) (34)
- Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs. (2004) (34)
- Enantiospecific synthesis of D-α, ω-diaminoalkanoic acids (1988) (33)
- Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain. (2016) (33)
- Study of adrenocorticotropic hormone conformation by evaluation of intramolecular resonance energy transfer in N -dansyllysine 21 -ACTH-(1-24)-tetrakosipeptide. (1972) (33)
- Conformation‐Activity relationships of cyclic dermorphin analogues (1990) (33)
- Inverse Agonism and Neutral Antagonism at Wild-Type and Constitutively Active Mutant Delta Opioid Receptors (2005) (32)
- Synthesis and biological activity of [Leu5]enkephalin derivatives containing D-glucose. (2009) (31)
- Cyclic and acyclic partial retro-inverso enkephalinamides: Mu receptor selective enzyme resistant analogs. (1983) (31)
- The octapeptide angiotensin II adopts a well-defined structure in a phospholipid environment. (1998) (31)
- Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold. (2005) (30)
- "Carba"-analogues of fentanyl are opioid receptor agonists. (2010) (30)
- Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides (1983) (29)
- Theoretical conformational analysis of a μ‐selective cyclic opioid peptide analog (1987) (29)
- Synthesis and characterization of ruthenium complexes containing tridentate P3O93-, Nb2W4O194-, and Cp*TiW5O183- ligands (1993) (29)
- Impact of the prorenin/renin receptor on the development of obesity and associated cardiometabolic risk factors (2014) (29)
- Biological activities of cyclic enkephalin pseudopeptides containing thioamides as amide bond replacements. (1989) (28)
- Matrix-assisted laser desorption/ionization mass spectrometric quantification of the mu opioid receptor agonist DAMGO in ovine plasma. (2000) (28)
- Comparative analysis of various proposed models of the receptor‐bound conformation of H‐tyr‐Tic‐Phe OH related δ‐opioid antagonists (1995) (28)
- Hormone—receptor interactions: [4‐Carboranylalanine, 5‐leucine] ‐ enkephalin as a structural probe for the opiate receptor (1977) (28)
- Variation of the net charge, lipophilicity, and side chain flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution. (2012) (28)
- Conformational studies of stereoisomeric 14‐membered cyclic enkephalin analogues containing 1‐naphthyialanine at the fourth position: Chirality effect of leucine at the fifth position on biological activity and receptor selectivity (1991) (28)
- In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera (2012) (28)
- Synthesis, opiate receptor affinity, and conformational parameters of [4-tryptophan]enkephalin analogues. (1978) (27)
- Radioimmunoassay of Atrial Natriuretic Factor (ANF) in Rat Atria (1984) (27)
- Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice. (2018) (27)
- Blood-brain barrier penetration by two dermorphin tetrapeptide analogues: role of lipophilicity vs structural flexibility. (2008) (26)
- Theoretical conformational analysis of the opioid δ antagonist H‐Tyr‐Tic‐Phe‐OH and the μ agonist H‐Tyr‐D‐Tic‐Phe‐NH2 (1994) (26)
- Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics. (2015) (26)
- Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. (2017) (26)
- Conformational Analysis of Enkephalin and Conformation – Activity Relationships (1984) (26)
- A New Structural Motif for μ-Opioid Antagonists (2005) (25)
- Synthesis and activity profiles of atrial natriuretic peptide (ANP) analogs with reduced ring size. (1986) (25)
- Conformational studies of diastereomeric cyclic enkephalins by 1H‐NMR and computer simulations (1987) (25)
- Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics. (1999) (24)
- Enkephalin analogues containing β‐naphthylalanine at the fourth position (1990) (24)
- Structure-activity relationships of dynorphin a analogues modified in the address sequence. (2003) (24)
- Methionine-enkephalin related glycoconjugates. Synthesis and biological activity. (2009) (23)
- Conversion of δ-, κ- and μ-receptor selective opioid peptide agonists into δ-, κ- and μ-selective antagonists (2003) (23)
- Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments. (2002) (23)
- Highly potent fluorescent analogues of the opioid peptide [Dmt1]DALDA (2003) (23)
- A chimeric opioid peptide with mixed μ agonist/δ antagonist properties (2004) (23)
- Development of Receptor-Selective Opioid Peptide Analogs as Pharmacologic Tools and as Potential Drugs (1993) (22)
- Stereospecific synthesis of (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide. (2001) (22)
- Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP. (1993) (22)
- Cyclic dermorphin tetrapeptide analogues obtained via ring-closing metathesis. (2006) (22)
- 1H n.m.r. investigation of conformational features of cyclic enkephalinamide analogs. (2009) (21)
- Glycoconjugates of opioid peptides. Synthesis and biological activity of [Leu5]enkephalin related glycoconjugates with amide type of linkage. (2009) (21)
- Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. (1995) (21)
- Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin (1980) (21)
- Cyclic Opioid Peptide Agonists and Antagonists Obtained Via Ring‐Closing Metathesis (2009) (21)
- SPONTANEOUS DIKETOPIPERAZINE FORMATION VIA END-TO-END CYCLIZATION OF A NONACTIVATED LINEAR TRIPEPTIDE : AN UNUSUAL CHEMICAL REACTION (1994) (21)
- Determination of the intramolecular tyrosine-tryptophan distance in a 7-peptide related to the C-terminal sequence of cholecystokinin. (2009) (21)
- Systemic and Spinal Analgesic Activity of a δ-Opioid-Selective Lanthionine Enkephalin Analog (2003) (21)
- FOUR DIFFERENT TYPES OF OPIOID PEPTIDES WITH MIXED μ AGONIST/δ ANTAGONIST PROPERTIES (1995) (21)
- Synthesis and biological activity of some glucose-enkephalin conjugates. (2009) (21)
- Synthesis of 4-amino-3-oxo-tetrahydroazepino[3,4-b]indoles: new conformationally constrained Trp analogs (2007) (21)
- Synthesis, in vitro opiate activity, and intramolecular tyrosine--tryptophan distances of [4-tryptophan]enkephalin analogues. A reassessment of conformational models of enkephalin in solution. (1980) (20)
- Fluorescence study on the conformation of a cyclic enkephalin analog in aqueous solution. (1983) (20)
- Deltorphin analogs restricted via a urea bridge: structure and opioid activity (2008) (20)
- Chemical deglycosylation of ovine pituitary lutropin. A study of the reaction conditions and effects on biochemical, biophysical and biological properties of the hormone. (1982) (20)
- Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human δ-Opioid Receptor with an Inverse Agonist (2005) (20)
- Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity. (2001) (20)
- Synthesis and biological activity of a linear fragment of the atrial natriuretic factor (ANF). (1985) (19)
- Peripheral antinociceptive effect of an extremely mu-selective polar dermorphin analog (DALDA). (1990) (19)
- Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics. (2015) (19)
- Fluorescence study on the solution conformation to dynorphin in comparison of enkephalin. (2009) (19)
- Electronic, steric, and hydrophobic factors influencing the action of enkephalin-like peptides on opiate receptors. (1981) (19)
- Synthesis and solution conformation of [Trp1, Val5]-angiotensin II. (1977) (18)
- Structural Modifications of the N-terminal Tetrapeptide Segment of [D-Ala2]Deltorphin I: Effects on Opioid Receptor Affinities and Activities In Vitro and on Antinociceptive Potency (1997) (18)
- Hybrid bivalent ligands with opiate and enkephalin pharmacophores. (1987) (18)
- Comparative structure-function studies with analogs of dynorphin-(1-13) and [Leu5]enkephalin. (1982) (18)
- Interaction of agonist peptide [3H]Tyr-d-Ala-Phe-Phe-NH2 with μ-opioid receptor in rat brain and CHO-μ/1 cell line (1998) (18)
- Prostaglandins can prevent the binding of chloroquine to calf thymus DNA. (1976) (18)
- [Pro(3)]Dyn A(1-11)-NH(2): a dynorphin analogue with high selectivity for the kappa opioid receptor. (2000) (18)
- β-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent δ opioid antagonists (2007) (17)
- Endocytic Profiles of δ-Opioid Receptor Ligands Determine the Duration of Rapid but Not Sustained cAMP Responses (2014) (17)
- A murine monoclonal antibody against rat atrial natriuretic factor (ANF) which cross-reacts with mouse ANF. (1987) (17)
- Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1). (2009) (17)
- [Aladan3]TIPP: A fluorescent δ‐opioid antagonist with high δ‐receptor binding affinity and δ selectivity (2005) (17)
- Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats (2010) (17)
- Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors. (2002) (16)
- Synthesis and opioid activity profiles of cyclic dynorphin analogs (1988) (16)
- Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations. (2013) (16)
- Highly efficient photoaffinity labeling of the hormone binding domain of atrial natriuretic factor receptor. (1992) (16)
- Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats (2013) (16)
- A novel cyclic enkephalin analogue with potent opioid antagonist activity. (2004) (16)
- [D‐Ala2, Phe (p‐NO2)4, Leu5]Enkephalin Amide and Nα‐[D‐Ala2, Leu5]‐Enkephalyl‐Nε‐Acetyl‐Lysine Amide: Synthesis and Biological Properties of Prospective Enkephalin Cooperative‐Affinity and Photoaffinity Labels. Preliminary communication (1979) (15)
- [Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile. (2014) (15)
- Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure. (2008) (15)
- Superactive analogs of the atrial natriuretic peptide (ANP). (1987) (15)
- Conformational behavior of [Trp4, Met5]-enkephalin: comparison of fluorescence parameters at different Ph. (1977) (15)
- [Hormone-receptor-relationships: synthesis and characteristics of N-epsilon-dansyllysine 21-adrenocorticotropin-(1-24)-tetrakosipeptide]. (1971) (15)
- Structure-activity relationships of cyclic β-casomorphin-5 analogues (1991) (15)
- Solid-Phase Azopeptide Diels-Alder Chemistry for Aza-pipecolyl Residue Synthesis To Study Peptide Conformation. (2019) (15)
- Covalent attachment of fluorescent probes to the X-base of Escherichia coli phenylalanine transfer ribonucleic acid. (1977) (14)
- Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling. (2019) (14)
- Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge (2005) (14)
- Systemic and spinal analgesic activity of a delta-opioid-selective lanthionine enkephalin analog. (2003) (14)
- Synthesis of a novel side‐chain to side‐chain cyclized enkephalin analogue containing a carbonyl bridge (1997) (14)
- Potent side‐chain to side‐chain cyclized dermorphin analogues containing a carbonyl bridge (2003) (14)
- In vivo disposition of dermorphin analog (DALDA) in nonpregnant and pregnant sheep. (1998) (14)
- Synthesis of 8-L-tryptophan-oxytocin and determination of one of its conformational parameters. (2009) (14)
- Quantitative analysis of [Dmt1]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry (2004) (14)
- 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. I. Synthesis and biological activity. (2009) (13)
- Activity profiles of novel side-chain to side-chain cyclized opioid peptide analogs (1984) (13)
- Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids. (1995) (13)
- Renal effects of TAPP, a highly selective μ‐opioid agonist (1996) (13)
- Radiosynthesis and in vivo evaluation of the pseudopeptide δ-opioid antagonist [125I]-ITIPP(ψ) (2001) (13)
- Hydrophobic forces are responsible for the folding of a highly potent natriuretic peptide analogue at a membrane mimetic surface: an NMR study. (1997) (13)
- Morphine-like activity of sheep β-lipotropin and of its tryptic fragments (1977) (13)
- The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds. (2009) (13)
- Structure-activity relationships of cyclic enkephalin analogs (1982) (12)
- Acetylated glucopyranosyl esters of enkephalins. (2009) (12)
- Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity. (2005) (12)
- Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries. (1995) (12)
- Effects of morphine, H‐Tyr‐d‐Arg‐Phe‐Lys‐NH2 (DALDA) and B‐HT920 on non‐cholinergic nerve‐mediated bronchoconstriction in pithed guinea‐pigs (1990) (12)
- Comparative conformational analysis of % MathType!MTEF!2!1!+-% feaafeart1ev1aaatCvAUfeBSjuyZL2yd9gzLbvyNv2CaerbuLwBLn% hiov2DGi1BTfMBaeXatLxBI9gBaerbd9wDYLwzYbItLDharqqtubsr% 4rNCHbGeaGqiVu0Je9sqqrpepC0xbbL8F4rqqrFfpeea0xe9Lq-Jc9% vqaqpepm0xbba9pwe9Q8fs0-yqaqpepae9pg0FirpepeKkFr0xfr-x% fr-xb9adbaqaa (1991) (12)
- Reverse turn mimics (1988) (12)
- The bifunctional μ opioid agonist/antioxidant [Dmt(1)]DALDA is a superior analgesic in an animal model of complex regional pain syndrome-type i. (2015) (12)
- Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists. (2008) (12)
- A conformational comparision of two stereoisomeric cyclic dermorphin analogues employing nmr and computer simulations (1990) (11)
- Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice (2016) (11)
- A novel side‐chain‐linked antiparallel cyclic dimer of enkephalin (1985) (11)
- N‐Methylated Cyclic Enkephalin Analogues Retain High Opioid Receptor Binding Affinity (2010) (11)
- Differential sensitivities of mouse strains to morphine and [Dmt1]DALDA analgesia (2003) (11)
- N‐(ureidoethyl)amides of cyclic enkephalin analogs (2009) (11)
- TIPP[ψ], a highly selective δ ligand (1994) (11)
- Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy. (2005) (11)
- [Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity (2008) (11)
- Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems. (1996) (10)
- Opioid dipeptide derivatives with a mixed μ antagonist/δ antagonist, partial μ agonist/δ antagonist or μ agonist/partial δ agonist profile (2002) (10)
- In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt1-DALDA Analogues. (2014) (10)
- Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment (2004) (10)
- Superior Analgesic Effect of H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2 ([Dmt1]DALDA), a Multifunctional Opioid Peptide, Compared to Morphine in a Rat Model of Neuropathic Pain (2012) (10)
- TIPP opioid peptides: Development of extraordinarily potent and selective δ antagonists and observation of astonishing structure-intrinsic activity relationships (1994) (10)
- FRAGMENT OF SHEEP BETA-LIPOTROPIN WITH MORPHINE-LIKE ACTIVITY (1976) (10)
- Synthesis, Characterization, and Biological Properties of Five Enkephalin‐like Pentapeptides Containing p‐Nitrophenylalanine (1981) (10)
- An enzymatically stable kyotorphin analog induces pain in subattomol doses☆ (2000) (10)
- p‐Nitrophenoxycarbonyl derivatives of Boc‐protected diaminoalkanes in the synthesis of enkephalin peptidomimetics (2005) (9)
- Highly potent side chain–main chain cyclized dermorphin–deltorphin analogues: An integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling (1995) (9)
- Differential Analgesic Effects of a Mu-Opioid Peptide, [Dmt1]DALDA, and Morphine (2008) (9)
- Cyclic enkephalin analogues containing alpha-amino-beta-mercapto-beta,beta-pentamethylenepropionic acid at positions 2 or 5. (1989) (9)
- Stereospecific Syntheses of 2-Alkyl and 2-Phenyl Substituted 3-(2,6-Dimethyl-4-hydroxyphenyl)propanoic Acids (2001) (8)
- Characterization of the Binding of [3H][Dmt1]H-Dmt-d-Arg-Phe-Lys-NH2, a Highly Potent Opioid Peptide (2003) (8)
- Chapter 3 – Application of Fluorescence Techniques in Studies of Peptide Conformations and Interactions (1985) (8)
- Differential respiratory effects of [Dmt1]DALDA and morphine in mice. (2005) (8)
- Distinct conformational preferences of three cyclic beta-casomorphin-5 analogs determined using NMR spectroscopy and theoretical analysis. (2009) (8)
- Strengthening peptide-based drug activity with novel glyconanoparticle (2018) (8)
- Synthesis of side-chain to side-chain cyclized peptide analogs on solid supports (2009) (8)
- In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs. (1986) (8)
- One-Pot Isomerization–Cross Metathesis–Reduction (ICMR) Synthesis of Lipophilic Tetrapeptides (2014) (8)
- A novel cis-peptide bond motif inducing beta-turn type VI. The synthesis of enkephalin analogues modified with 4-aminopyroglutamic acid. (2001) (8)
- Ureido group containing cyclic dermorphin(1–7) analogues: synthesis, biology and conformation (2007) (8)
- N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile. (2013) (8)
- Synthesis of cyclic dipeptide templates, their incorporation into peptides and studies on their conformational and biological properties. (2009) (8)
- The TIPP opioid peptide family: Development of a new class of highly potent δ-receptor antagonists with extraordinary δ-selectivity (1993) (8)
- Replacement of the N-terminal tyrosine residue in opioid peptides with 3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid (Dcp) results in novel opioid antagonists. (2006) (8)
- Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity. (2009) (8)
- Formation Pathways and Opioid Activity Data for 3‐Hydroxypyridinium Compounds Derived from Glucuronic Acid and Opioid Peptides by Maillard Processes (2007) (7)
- A chimeric opioid peptide with mixed mu agonist/delta antagonist properties. (2004) (7)
- 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode. (2014) (7)
- Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro. (2009) (7)
- Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain. (2020) (7)
- The μ Opioid Receptor Binding Pharmacophore Conformation of Ornithine Containing Cyclic β‐Casomorphin Analogues and Related Peptides (1995) (7)
- Molecular dynamics simulations of opioid peptide analogs containing multiple conformational restrictions. (2009) (7)
- Potent Opioid Peptide Agonists Containing 4′‐[N‐((4′‐phenyl)‐phenethyl)carboxamido]phenylalanine (Bcp) in Place of Tyr (2008) (7)
- Dansylated analogues of the opioid peptide [Dmt1]DALDA: in vitro activity profiles and fluorescence parameters. (2004) (7)
- Synthesis of peptidomimetics: An evaluation of the p-nitrophenyl carbamate of ethylenediamine (2004) (7)
- [35S]GTPγS binding stimulated by endomorphin-2 and morphiceptin analogs (2006) (7)
- Tyrosine-iodination converts the δ-opioid peptide antagonist TIPP to an agonist (1995) (7)
- SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION IN VITRO OF CYCLIC ENKEPHALIN ANALOGS: EFFECT OF CONFORMATIONAL CONSTRAINTS ON OPIATE RECEPTOR SELECTIVITY (1983) (7)
- Aggregation behaviour and Zn2+ binding properties of secretin. (1998) (6)
- Novel opioid peptide analogs with mixed µ agonist/δ antagonist properties (1995) (6)
- SHORT-TERM TREATMENT OF THE HUMAN DELTA-OPIOID RECEPTOR WITH AN INVERSE AGONIST" (2004) (6)
- Synthesis and binding characteristics of [3H] H-Tyr-Ticψ[CH2-NH] Cha-Phe-OH, a highly specific and stable δ-opioid antagonist (1999) (6)
- Conformational comparison of (Val5, Trp8)-angiotensin II and (Val4, Trp7)-angiotensin III by fluorescence measurements. (1979) (6)
- The Cardiovascular and Renal Effects of the Potent and Highly Selective μ Opioid Agonist [Dmt1]DALDA (2004) (6)
- Determination of the average end-to-end distance of two angiotensin II analogs by resonance energy transfer. (2009) (6)
- Natriuretic Factor (ANF) in the Heart of Various (1985) (6)
- A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists. (2016) (6)
- SYNTHESIS AND OPIOID ACTIVITY PROFILES OF PROENKEPHALIN (100-111) ANALOGS (2010) (5)
- Enkephalin analogs containing 4,4‐difluoro‐2‐aminobutyric acid: Synthesis and fluorine effect on the biological activity (1998) (5)
- Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery (2018) (5)
- Radiosynthesis and in vivo evaluation of the pseudopeptide delta-opioid antagonist [(125)I]ITIPP(psi). (2001) (5)
- Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists. (2007) (5)
- Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists. (2003) (5)
- Conformational restriction of the Phe3 residue in a cyclic dermorphin analog: Effects on receptor selectivity and stereospecificity (1992) (5)
- Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H‐Tyr‐TicΨ[CH2‐NH] Phe‐OH) incorporating a reduced peptide bond: An NMR investigation (1995) (5)
- The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors. (1983) (5)
- Synthesis and Opioid Activity Profiles of Cyclic Dynorphin Analogs. (1988) (4)
- Development of potent opioid δ antagonists and mixed μ agonist / δ antagonists (1995) (4)
- Synthesis and biological activity of homoarginine‐containing opioid peptides (2007) (4)
- Development of Receptor‐Specific Opioid Peptide Analogs (1992) (4)
- Synthesis and Opiate Activity in vitro of Five New p-Nitrophenylalanine4-Enkephalin-like Peptides (1983) (4)
- Characterization of Analgesic Actions of the Chronic Intrathecal Infusion of H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2 in Rat (2019) (4)
- Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists. (2012) (4)
- Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine (2004) (4)
- Alterations in biological activities induced by glycation of leucine-enkephalin with different monosaccharide moieties (1996) (4)
- Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity. (2011) (4)
- Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H‐Tyr‐c[D‐Cys‐Gly‐Phe(pNO2)‐D‐Cys]‐NH2 containing (S)‐α‐hydroxymethylcysteine in place of cysteine (2005) (4)
- Side chain to side chain cyclization of an enkephalin analog results in loss of opioid receptor selectivity. (2009) (4)
- [Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. (2016) (4)
- Opioid peptide analogs with novel activity profiles as potential therapeutic agents for use in analgesia (1999) (4)
- Comparative conformational analysis of [D-Pen2, D-Pen5]enkephalin (DPDPE): A molecular mechanics study (1991) (4)
- Proton NMR Conformational Analysis of Cyclic β‐Casomorphin Analogues of the Type Tyr‐cyclo[‐Nω‐D‐Orn‐Xaa‐Yaa‐Gly‐] (1996) (4)
- Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes (2021) (3)
- Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides. (1983) (3)
- Equipotent enantiomers of cyclic opioid peptides at μ opioid receptor (2019) (3)
- DALDA AND DAMGO IN BINDING AND G PROTEIN ACTIVATION AT MU , DELTA AND KAPPA OPIOID RECEPTORS (2003) (3)
- Orientation of the tryptophanyl side chain in [(d)TrpA1] and [TrpA1]insulin (1983) (3)
- TIPP analogs: Highly selective δ opioid antagonists with subnanomolar potency and first known compounds with mixed μ agonist/δ antagonist properties (1994) (3)
- Synthesis and binding characteristics of [3H] H-Tyr-Ticpsi[CH2-NH] Cha-Phe-OH, a highly specific and stable delta-opioid antagonist. (1999) (3)
- Optically active aromatic amino acids. Part VI. Synthesis and properties of [Leu5]‐enkephalin analogues containing O‐methyl‐L‐tyrosine1 with ring substitution at position 3′ (2000) (3)
- Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings. (2018) (3)
- A General New Concept for the Development of Opioid Peptide Derived μ-, δ- and κ-Antagonists (2001) (3)
- χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds. (2017) (3)
- DALDA analogues containing alpha-hydroxymethylamino acids. (2001) (3)
- Bifunctional μ/δ Opioid Peptides: Variation of the Type and Length of the Linker Connecting the Two Components (2012) (3)
- [(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs. (2006) (3)
- A new structural motif for mu-opioid antagonists. (2005) (3)
- Conformationally constrained opioid peptide analogs with novel activity profiles (1998) (3)
- Synthesis and bioactivity studies of 1‐adamantanamine derivatives of peptides (1995) (3)
- Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp]. (2008) (3)
- Intramuscular and subcutaneous administration of atrial natriuretic factor in the rat. (1989) (3)
- The use of multiple conformational restriction in the development of opioid peptidomimetics (1991) (3)
- COMPARISON OF [DMT]DALDA AND DAMGO IN BINDING AND G PROTEIN ACTIVATION AT MU, DELTA AND KAPPA OPIOID RECEPTORS (2003) (3)
- Structural and Pharmacological Aspects of Peptidomimetics (2003) (2)
- Novel ligands lacking a positive charge for the delta- and mu-opioid receptors. (2000) (2)
- Effect of aromatic amino acid substitutions in the 3‐position of cyclic β‐casomorphin analogues on μ‐opioid agonist/δ‐opioid antagonist properties* (2009) (2)
- Synthesis and In Vitro Opioid Activity Profiles of Novel Cyclic Enkephalin Analogs (2006) (2)
- Role of the conformational element in peptide-receptor interactions. Studies with cyclic opioid peptide analogs. (1988) (2)
- Spectroscopic analysis of [Trp3]-beta-casomorphin analogs. Comparative structure conformation-activity studies. (2009) (2)
- Deltorphin analogs restricted via a urea bridge: structure and opioid activity. (2009) (2)
- Development of opioid peptide analogs as pharmacologic tools and as potential drugs: current status and future directions. (1991) (2)
- Structure-Activity Relationships of Atrial Natriuretic Peptides (1987) (2)
- Theoretical conformational analysis of μ-selective cyclic opioid peptide analogs (1988) (2)
- CONFORMATIONAL ASPECTS OF THE ENKEPHALIN–OPIATE RECEPTOR INTERACTION (1981) (1)
- Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties. (1996) (1)
- Morphine-like activity of sheep beta-lipotropin and of its tryptic fragments. (1977) (1)
- A new class of dipeptide derivatives that are potent and selective δ opioid agonists (2002) (1)
- Synthesis and biological activity of linear and cyclic enkephalins modified at the Gly3-Phe4 amide bond. (1985) (1)
- Conformation-activity relationships of cyclo-constrained mu/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin. (2009) (1)
- Synthesis and activity profiles of bivalent [Leu5]enkephalin-α-oxymorphamine hybrid opioid receptor ligands (1988) (1)
- In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera (2012) (1)
- Synthesis and biological activity profiles of atrial natriuretic factor (ANF) analogs. (2009) (1)
- Synthesis and pharmacological evaluation of highly potent [Dmt1]DALDA analogs. (2009) (1)
- Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2. (1994) (1)
- Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist. (1995) (1)
- New Concepts in Peptide Analog Design (1988) (1)
- Bi- or multifunctional peptide drugs (2010) (1)
- The Use of Steady-State Fluorescence Techniques in the Conformational Analysis of Polypeptides (1981) (1)
- SYNTHESIS, OPIATE RECEPTOR AFFINITY, AND CONFORMATIONAL PARAMETERS OF (4-TRYPTOPHAN)ENKEPHALIN ANALOGS (1979) (1)
- Affinity chromatography of phenylalanyl-tRNA synthetase. (1974) (1)
- Interpretation of the fluorescence decay characteristics of cyclic β-casomorphin analogs based on theoretically calculated ensembles of their low energy conformers (2002) (1)
- Spontaneous diketopiperazine formation via end to end cyclization of a non-activated linear tripeptide (1995) (0)
- Corrigendum to "Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings" [Bioorg. Med. Chem. Lett. 28(13) (2018) 2320-2323]. (2018) (0)
- Protective effect of a mitochondria‐targeting peptide against paclitaxel‐induced peripheral neuropathy (2022) (0)
- Stereospecific Syntheses of 2-Alkyl and 2-Phenyl Substituted 3-(2,6-Dimethyl-4-hydroxyphenyl)propanoic Acids. (2010) (0)
- Analogs of the δ opioid antagonist TIPP with increased lipophilic character (2002) (0)
- A method for the prevention of mitochondrial permeability transition (2004) (0)
- TIPP[psi], a highly selective delta ligand. (1994) (0)
- Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt1]DALDA (H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2) (2020) (0)
- Synthesis and evaluation of some highly potent [Dmt(1)]DALDA analogs (2006) (0)
- SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF SIDE-CHAIN TO SIDE-CHAIN CYCLIZED OPIOID PEPTIDE ANALOGS (1987) (0)
- [Development of new drugs based on the structure of natural polypeptides]. (1988) (0)
- Abstract 3882: Selective Inhibition of Mitochondrial ROS Attenuates TNF-alpha Expression in Cardiomyocytes and Preserves Myocardial Function in Endotoxemic Mice (2009) (0)
- Synthesis of the diastereomers of β-Me-Tyr and β-Me-Phe and their effect on the biological properties of the delta opioid receptor antagonist TIPP (1995) (0)
- Mechanisms Implicated in the Reduced Fat Mass and Improved Glucose Homeostasis Observed in Obese Mice Treated with a Prorenin/Renin Receptor Blocker (2015) (0)
- Direct Electrophilic Fluorination of Tyrosine in Dermorphin Analogues and Its Effect on Biological Activity, Receptor Affinity, and Selectivity. (1991) (0)
- Design and synthesis of a conformational mimetic of β-turn secondary structure (1994) (0)
- Synthesis and biological activity of linear and cyclic enkephalins modified at the Gly3‐Phe4amide bond (2009) (0)
- American Peptide Society NEWS (2009) (0)
- SYNTHESIS, IN VITRO OPIATE ACTIVITY, AND INTRAMOLECULAR TYROSINE‐TRYPTOPHAN DISTANCES OF (4‐TRYPTOPHAN)ENKEPHALIN ANALOGS. A REASSESSMENT OF CONFORMATIONAL MODELS OF ENKEPHALIN IN SOLUTION (1980) (0)
- Molecular Model of the BNP-NPR-A Receptor Complex (2001) (0)
- AUnified Polymerase Mechanism for Nonhomologous DNAandRNAPolymerases (2015) (0)
- A uniform model explaining structure-activity relationships of opiates and β-casomorphins derived from molecular modelling and 1H NMR studies (1993) (0)
- Chiral synthesis of D-α, ω-diaminoalkanoic acids (1988) (0)
- 1H NMR spectroscopic studies reveal multiple conformers of cyclic opioid peptide analogs (1992) (0)
- A Novel Cyclic Opioid Peptide Antagonist Containing a Hydroxy Group in Place of the N-Terminal Amino Function (2001) (0)
- [The structural basis of the morphinomimetic action of enkephalin]. (1977) (0)
- Comparison of [Dmt 1 ]DALDA and DAMGO in Binding and G Protein Activation at (cid:1) , (cid:2) , and (cid:3) Opioid Receptors (2003) (0)
- Synthesis and pharmacological characterization of a cyclic β-casomorphin analog with mixed μ agonist/δ antagonist properties (1994) (0)
- Design, Anti-Hiv Activity, Cellular Pharmacology and Conformation of BCH-189 [(±)3TC], A Novel Nucleoside Analogue (1992) (0)
- ROLE OF (PRO)RENIN RECEPTOR BLOCKADE IN PREVENTING OBESITY AND OBESITY-RELATED DISEASE: PP.LB3.444 (2011) (0)
- Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists (2013) (0)
- Methodes de prevention de la transition de la permeabilite mitochondriale (2004) (0)
- Synthesis and Activity Profiles of Novel Cyclic Opionic Peptide Monomers and Dimers. (1986) (0)
- Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-]. (1996) (0)
- The (pro)renin receptor blocker peptide effects on regulation of body weight and glucose homeostasis in mice with diet‐induced obesity (1101.10) (2014) (0)
- Conformationally constrained opioid peptide analogs with novel activity profiles (2004) (0)
- Evaluation of constrained amino acids in the design of neurokinin 1 receptor- and bifunctional opioid – neurokinin 1 receptor ligands (2011) (0)
- DALDA analogues containing-hydroxymethylamino acids (2001) (0)
- The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonists. (1993) (0)
- Conformational analysis of cyclic opioid peptide analogs. (1988) (0)
- (D-ALA2,PHE(P-NO2)4,LEU5)ENKEPHALIN AMIDE AND Nα-(D-ALA2,LEU5)ENKEPHALYL-Nε-ACETYL-LYSINE AMIDE: SYNTHESIS AND BIOLOGICAL PROPERTIES OF PROSPECTIVE ENKEPHALIN COOPERATIVE-AFFINITY AN PHOTOAFFINITY LABELS (1979) (0)
- N-{epsilon}-Dansyllysin-21-adrenocorticotropin-(1-24)- tetrakosipeptid (1971) (0)
- CB&DD Editorial Advisory Board (fourth in series) (2006) (0)
- Enkephalin analogues containing beta-naphthylalanine at the fourth position. (1990) (0)
- Synthesis, conformational analysis, and biological activity of opioid peptide analogs containing side chain fluorinated amino acids (1999) (0)
- Quantitative analysis of [Dmt(1)]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry. (2004) (0)
- A comparison of the analgesic effects of H-Dmt-D-Arg-Phe-Lys-NH2, a synthetic opioid peptide, and morphine in experimental neuropathic pain (2012) (0)
- Synthesis of peptidomimetics: An evaluation of p-nitrophenyl carbamate of ethylenediamine (2006) (0)
- TWO NEW CLASSES OF CYCLIC ENKEPHALIN ANALOGS WITH HIGH POTENCY AND SPECIFICITY FOR μ-RECEPTORS (1981) (0)
- species. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal (2011) (0)
- Stereoselective synthesis of (3S)- and (3R)-3-hydroxy-3-(2,6-dimethyl-4-hydroxyphenyl)propanoic acid and its incorporation into a cyclic enkephalin analogue. (2009) (0)
- Synthesis and opioid activity of cyclic ß-casomorphin analogs (1991) (0)
- Synthesis and biological evaluation of a compact, conformationally constrained bifunctional opioid agonist-neurokin-1 antagonist (2014) (0)
- Enantiospecific Synthesis of D-α,ω-Diaminoalkanoic Acids (X). (1988) (0)
- Synchrotron structure of the human delta opioid receptor in complex with a bifunctional peptide (PSI community target) (2015) (0)
- Antagonism as a consequence of side chain conformational restriction: A new class of potent, δ opioid receptor-selective peptide antagonists (1993) (0)
- Synthesis and opioid activity profile of some glycoconjugates of methionine-enkephalin and related peptides (1993) (0)
- Enhanced efficacy (intrinsic activity) of cyclic opioid peptide analogs at the. mu. -receptor (1986) (0)
- H-Tyr-Tic-Phe-OH related δ opioid agonists and antagonists have similar receptor-bound conformations but different pharmacophores (2002) (0)
- Cyclic casomorphin analogs with improved δ antagonist potency (1995) (0)
- Peptidomimetic opioids--synthesis, spectroscopy, and computer simulations. (1991) (0)
- Author index for volume 82 (2002) (0)
- Structural modification and biological evaluation of Dmt1-DALDA analogues (2011) (0)
- Endocytic Profiles of d-Opioid Receptor Ligands Determine the Duration of Rapid but Not Sustained cAMP Responses s (2013) (0)
- XFEL structure of the human delta opioid receptor in complex with a bifunctional peptide (2015) (0)
- Structure-activity relationships of cyclic beta-casomorphin-5 analogues. (1991) (0)
- Opioid peptide analogs as pharmacological tools and as potential drugs (1995) (0)
- SYNTHESIS, CHARACTERIZATION, AND BIOLOGICAL PROPERTIES OF FIVE ENKEPHALIN-LIKE PENTAPEPTIDES CONTAINING P-NITROPHENYLALANINE (1982) (0)
- Conformational analysis of opioid peptides and the use of conformational restriction in the design of selective analogs. (1986) (0)
- Uses aromatic cationic peptides (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter Wilhelm Schiller?
Peter Wilhelm Schiller is affiliated with the following schools:
